针对癌症的MHC-I分子:功能,机制和治疗前景
Xiangyu Wu1, Tianhang Li2,3, Rui Jiang4
1Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Molecular cancer
|December 1, 2023
概括
主体组织相容性I类 (MHC-I) 分子对于免疫检测至关重要. 异常的MHC-I功能有助于癌症免疫逃避,突出其在癌症免疫治疗中的重要性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 主体组织相容性I类 (MHC-I) 分子在细胞表面上呈现,向免疫细胞发出信号,以识别和消除感染或癌细胞等威胁.
- 瘤细胞可以利用异常的MHC-I表达和功能来逃避免疫监测,促进癌症的进展并阻碍免疫治疗的有效性.
研究的目的:
- 审查有关MHC-I分子在癌症发展中的最新发现.
- 专注于瘤微环境中的MHC-I相互作用.
- 突出针对MHC-I的意义,以改善癌症免疫疗法和理解其机制.
主要方法:
- 关于MHC-I在癌症中的最新研究的文献综述.
- 对MHC-I与瘤微环境组件相互作用的分析.
- 讨论MHC-I针对癌症免疫疗法的策略.
主要成果:
- 在抗癌免疫监测中,MHC-I起着至关重要的作用.
- 瘤细胞经常操纵MHC-I以逃避免疫检测.
- 瘤微环境中的MHC-I相互作用是复杂的和多方面的.
结论:
- 了解MHC-I的作用对于开发有效的癌症免疫疗法至关重要.
- 针对MHC-I提供了一个有希望的策略来增强抗癌免疫力.
- 进一步研究MHC-I在癌症中的动态功能是有必要的.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Antigens Involved in Adaptive Immunity
502
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
502
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Antigen Processing Pathways
1.0K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
1.0K
Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


